11/18
08:12 am
lpcn
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session [Yahoo! Finance]
Medium
Report
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session [Yahoo! Finance]
11/18
08:00 am
lpcn
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session
High
Report
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session
11/7
08:00 am
lpcn
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024
Medium
Report
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024
10/31
08:00 am
lpcn
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea
Medium
Report
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea
10/14
11:09 pm
lpcn
Lipocine Inc. (NASDAQ: LPCN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
10/10
08:00 am
lpcn
Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results
Low
Report
Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results
10/8
08:00 am
lpcn
Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries
Low
Report
Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries
10/2
08:00 am
lpcn
Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024
Low
Report
Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024
9/30
08:00 am
lpcn
Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference
Low
Report
Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference
9/28
02:02 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
9/24
11:06 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $10.00 price target on the stock.
9/20
11:31 pm
lpcn
Lipocine Inc. (NASDAQ: LPCN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
High
Report
Lipocine Inc. (NASDAQ: LPCN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
9/5
08:00 am
lpcn
Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®
Low
Report
Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®
8/30
02:05 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
8/27
08:00 am
lpcn
Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference